IBTInternational Biotechnology Ord
LSE · GB · Healthcare
1120.00GBp-0.89%Mkt Cap: 385.95M $P/E: 4.63Today
Industry Peers
HealthcareKey Statistics
Company
Market Cap385.95M $
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-1.27M $
Revenue/Share—
Last Price1120.00 GBp
Fiscal Year End—
MR Quarter—
Employees—
CountryGB
SectorHealthcare
Industry—
ISIN—
Valuation
P/E (Trailing)4.63
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B1.14
EPS (TTM)—
EPS (Forward)—
52W Range
1082.0072% of range1135.00
52W High1135.00 GBp
52W Low1082.00 GBp
Profitability
Gross Margin—
Oper. Margin—
EBITDA Margin—
Profit Margin668.57%
ROE-0.47%
ROA-0.41%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF31.12M $
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.12
Current Ratio—
Quick Ratio—
Book Value/Sh9.885 GBp
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.3180 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.31.70M
Float—
Insiders—
Institutions—
Technical
SMA 501072.82 (+4.4%)
SMA 200978.71 (+14.4%)
Beta—
S&P 52W Chg—
Avg Vol (30d)106.44K
Avg Vol (10d)57.20K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—